A novel tumor-promoting mechanism of IL6 and the therapeutic efficacy of tocilizumab: Hypoxia-induced IL6 is a potent autophagy initiator in glioblastoma via the p-STAT3-MIR155-3p-CREBRF pathway

Hypoxia induces protective autophagy in glioblastoma cells and new therapeutic avenues that target this process may improve the outcome for glioblastoma patients. Recent studies have suggested that the autophagic process is upregulated in glioblastomas in response to extensive hypoxia. Hypoxia also...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Autophagy
Autors principals: Xue, Hao, Yuan, Guang, Guo, Xing, Liu, Qinglin, Zhang, Jinsen, Gao, Xiao, Guo, Xiaofan, Xu, Shugang, Li, Tong, Shao, Qianqian, Yan, Shaofeng, Li, Gang
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2016
Matèries:
Basic Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4990999/
https://ncbi.nlm.nih.gov/pubmed/27163161
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15548627.2016.1178446
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars